Hypoglycemic activity and stability enhancement of human insulin–tat mixture loaded in elastic anionic niosomes

References

• Brgles M, Jurašin D, Sikirić MD, et al. (2008). Entrapment of ovalbumin into liposomes – factors affecting entrapment efficiency, liposome size, and zeta potential. J Liposome Res 18:235–48
   PubMed Web of Science ®Google Scholar
• Brooks H, Lebleu B, Vivès E. (2005). Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 57:559–77
   PubMed Web of Science ®Google Scholar
• Christensen SD, Mikkelsen LF, Fels JJ, et al. (2009). Quality of plasma sampled by different methods for multiple blood sampling in mice. Lab Anim 43:65–71
   PubMed Web of Science ®Google Scholar
• El Maghraby GMM, Williams AC, Barry BW. (2004). Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 276:143–61
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–72
   PubMed Web of Science ®Google Scholar
• Fonseca SB, Pereira MP, Kelley SO. (2009). Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev 61:953–64
   PubMed Web of Science ®Google Scholar
• Ghanbarzadeh S, Arami S. (2013). Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. Biomed Res Int 2013:1–7
   Web of Science ®Google Scholar
• Gupta B, Levchenko TS, Torchilin VP. (2005). Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 57:637–51
   PubMed Web of Science ®Google Scholar
• Hansen M, Kilk K, Langel Ü. (2008). Predicting cell-penetrating peptides. Adv Drug Deliv Rev 60:572–9
   PubMed Web of Science ®Google Scholar
• Heller S, Kozlovski P, Kurtzhals P. (2007). Insulin's 85th anniversary – an enduring medical miracle. Diabetes Res Clin Pract 78:149–58
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Bouwstra JA. (2005). Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2:67–74
   PubMedGoogle Scholar
• Junyaprasert V, Teeranachaideekul V, Supaperm T. (2008). Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS Pharm Sci Tech 9:851–9
   PubMed Web of Science ®Google Scholar
• Khafagy E-S, Morishita M, Onuki Y, Takayama K. (2007). Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev 59:1521–46
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Suzuki N, Ebihara K, et al. (1999). Gene delivery using liposome technology. J Controlled Release 62:269–77
   PubMed Web of Science ®Google Scholar
• Koren E, Apte A, Sawant RR, et al. (2011). Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements. Drug Deliv 18:377–84
   PubMed Web of Science ®Google Scholar
• Liang JF, Yang VC. (2005). Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency. Biochem Biophys Res Commun 335:734–8
   PubMed Web of Science ®Google Scholar
• Manosroi A, Khanrin P, Lohcharoenkal W, et al. (2010a). Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 392:304–10
   PubMed Web of Science ®Google Scholar
• Manosroi A, Khanrin P, Werner RG, et al. (2010b). Entrapment enhancement of peptide drugs in niosomes. J Microencapsulation 27:272–80
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. (2003). Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces 30:129–38
   Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. (2005). The entrapment of kojic oleate in bilayer vesicles. Int J Pharm 298:13–25
   PubMed Web of Science ®Google Scholar
• Manosroi J, Khositsuntiwong N, Manosroi W, et al. (2013a). Potent enhancement of transdermal absorption and stability of human tyrosinase plasmid (pAH7/Tyr) by Tat peptide and an entrapment in elastic cationic niosomes. Drug Deliv 20:10–18
   PubMed Web of Science ®Google Scholar
• Manosroi J, Lohcharoenkal W, Götz F, et al. (2011a). Transdermal absorption enhancement of n-terminal Tat–GFP fusion protein (TG) loaded in novel low-toxic elastic anionic niosomes. J Pharm Sci 100:1525–34
   PubMed Web of Science ®Google Scholar
• Manosroi J, Moses ZZ, Manosroi W, Manosroi A. (2011b). Hypoglycemic activity of Thai medicinal plants selected from the Thai/Lanna Medicinal Recipe Database MANOSROI II. J Ethnopharmacol 138:92–8
   PubMed Web of Science ®Google Scholar
• Manosroi J, TangJai T, Werner RG, et al. (2013b). Potent and prolonged hypoglycemic activity of an oral insulin-Tat mixture in diabetic mice. Drug Res 63:1–6
   Google Scholar
• Nutan M, Reddy I. (2009). General principles of suspensions. In: Kulshreshtha A, Singh O, Wall G, eds. Pharmaceutical suspensions. London: Springer, 39–66
   Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–41
   PubMed Web of Science ®Google Scholar
• Persson D, Thorén PEG, Nordén B. (2001). Penetratin-induced aggregation and subsequent dissociation of negatively charged phospholipid vesicles. FEBS Lett 505:307–12
   PubMed Web of Science ®Google Scholar
• Rees DA, Alcolado JC. (2005). Animal models of diabetes mellitus. Diabetic Med 22:359–70
   PubMed Web of Science ®Google Scholar
• Sabetsky V, Ekblom J. (2010). Insulin: a new era for an old hormone. Pharm Res 61:1–4
   Web of Science ®Google Scholar
• Snow EK. (2009). AHFS drug information 2009. Bethesda, MD: American Society of Health – System Pharmacists
   Google Scholar
• Srinivasan K, Ramarao P. (2007). Animal models in type 2 diabetes research: an overview. Indian J Med Res 125:451–72
   PubMed Web of Science ®Google Scholar
• Stoyanova SD. (2004). Acid-PAGE for evaluation of tobacco varieties by polymorphism of alcohol soluble proteins in seeds. Biotechnol Biotechnol Equip 18:68–73
   Google Scholar
• Sun J-E, Ao Z-H, Lu Z-M, et al. (2008). Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. J Ethnopharmacol 118:7–13
   PubMed Web of Science ®Google Scholar
• Sunil AA, Sheetal SJ, Tejraj MA. (2006). Controlled release of cephalexin through gellan gum beads: Effect of formulation parameters on entrapment efficiency, size, and drug release. Eur J Pharm Biopharm 63:249–61
   PubMed Web of Science ®Google Scholar
• Tanquilut NC, Tanquilut MRC, Estacio MAC, et al (2009). Hypoglycemic effect of Lagerstroemia speciosa (L.) Pers. on alloxan-induced diabetic mice. J Med Plants Res 3:1066–71
   Google Scholar
• Uchegbu IF, Vyas SP. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70
   Web of Science ®Google Scholar
• Van Belle TL, Taylor P, von Herrath MG. (2009). Mouse models for type 1 diabetes. Drug Discov Today Dis Models 6:41–5
   PubMedGoogle Scholar
• van den Bergh BAI, Wertz PW, Junginger HE, Bouwstra JA. (2001). Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm 217:13–24
   PubMed Web of Science ®Google Scholar
• Vimalavathini R, Gitanjali B. (2009). Effect of temperature on the potency & pharmacological action of insulin. Indian J Med Res 130:166–9
   PubMed Web of Science ®Google Scholar